Lip and Chin Waxing on Isotretinoin With a Recent Peel and Tan
A 22-year-old woman with polycystic ovary syndrome requests lip, chin, and eyebrow waxing. She has coarse dark chin hairs and has been plucking daily. Her medications include isotretinoin 20 mg daily, started 5 months ago, tretinoin 0.025% cream nightly, and doxycycline 100 mg daily for acne. She had a “light chemical peel” at another salon four days ago and returned from a Florida vacation three days ago with a visible tan. She has no active cold sores, no bleeding, and no history of keloids. She wants the hair removed today because she has a job interview tomorrow. She asks whether threading would be safer than waxing. She is afebrile and her skin is intact but slightly pink and dry. She has not asked her prescriber about hair removal.
1. Identify and rank the contraindications to waxing in this client, with the recommended waiting period for each.
Read the worked answer
The strongest contraindication is isotretinoin. It thins the epidermis and impairs healing, so waxing can avulse skin and cause scarring; standard advice is to avoid waxing during treatment and for about 6 months after the last dose, with the prescriber’s guidance. Next is the recent chemical peel: the skin is still remodeling, and waxing too soon can tear it; wait at least 7–14 days depending on the peel’s depth and the client’s healing. Tretinoin is a topical retinoid that compromises the barrier; it is usually stopped 5–7 days before waxing, and she is using it nightly. Doxycycline causes photosensitivity, and she has a fresh tan; waxing tanned skin raises the risk of post-inflammatory hyperpigmentation and irritation. The tan itself is a reason to defer. Polycystic ovary syndrome explains the hirsutism but is not a contraindication. Because several contraindications overlap, the safe decision is to postpone all facial waxing.
2. How should you respond to her request and her question about threading?
Read the worked answer
Explain that waxing is not safe today because of the isotretinoin, tretinoin, recent peel, and fresh tan, and that the risk is skin tearing, scarring, and pigmentation rather than simply discomfort. Do not perform a patch test and proceed; a patch test does not rule out the systemic skin fragility caused by isotretinoin. Threading is also a mechanical trauma and is not a safe substitute while she is on isotretinoin and has recently had a peel; it can remove skin as well as hair. Safe options are gentle trimming with a clean scissors or an electric trimmer, avoiding the irritated areas, and rescheduling after she has stopped isotretinoin for the period her prescriber recommends and her skin has recovered from the peel and tan. Offer to contact her prescriber’s office with her permission. Set realistic expectations and do not promise that threading is “chemical-free” and therefore safe.
3. What documentation and referral, if any, are appropriate?
Read the worked answer
Document the medications, the date of the isotretinoin start, the recent peel, the tan, the visible pinkness and dryness, the refusal to wax, the explanation given, and the alternative recommended. Note that she was advised to consult her prescriber before any hair removal and to wait until the skin has normalized. Record that threading was also declined and why. A referral to the prescriber is appropriate for clearance and for guidance on hair removal while on isotretinoin; a dermatology referral is reasonable for the hirsutism if she has not had one. Do not chart a diagnosis of a skin disease; describe findings objectively. This documentation protects both the client and the esthetician if she later claims she was not warned about the risks.